Netherlands· NL-e01a6ba5a8e4

Eplerenon Synthon 50 mg, filmomhulde tabletten

A eplerenone product containing eplerenon, registered in Netherlands by Synthon B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC C03DA04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about eplerenonAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Eplerenone is registered in 17 of 19 countries.

Countries holding a registration under ATC C03DA04 (eplerenone), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search eplerenone products by name

Eplerenone · ATC C03DA04

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of eplerenone costs, country by country.

Normalised to the WHO defined daily dose (50 mg), the median price runs from $1.05 in France to $3.72 in Switzerland — a ×3.6 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Eplerenone · price per daily dose (50 mg)

USD · FX 28 Sept 2026

CH Switzerland$3.72
IT Italy$1.47
FR France$1.05

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: EPLERENON
Manufacturer: Synthon B.V.
Country: Netherlands (NL)
ATC code: C03DA04
ATC class: Eplerenone
Defined daily dose: 50 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
116346

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

230 interactions on record for eplerenone.

Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check eplerenone against other medicines How interaction checks work

Eplerenone · interactions on record

230 records

32 severe
97 moderate
3 minor
24 info

Most severe, free to view

ClotrimazoleA01AB18severe
AprepitantA04AD12severe
Potassium chlorideA12BA01severe
Potassium citrateA12BA02severe

74 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eplerenone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eplerenone products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Eplerenon +pharma, Eplerenon Actavis
Belgium · Eplerenone Ab, Inspra
Bulgaria · Eспиро, Аплериа
Cyprus · Apleria, Eplerenone Accord
Czechia · Apleria, Eplerenon Medreg
Germany · Epleraxiro, Eplerenon 1 A Pharma
Denmark · Eplerathen, Eplerenon Accord
Estonia · Apleria
Spain · Elecor, Eplerenona Alter
Finland · Inspra
France · Eplerathen, Eplerenone Accord
United Kingdom (Northern Ireland) · Eplerenone, Eplerenone Accord Healthcare
Greece · Apleria, Eleveon
Croatia · Apleria, Diuron
Hungary · Diupot, Eplerenon Krka
Ireland · Eplerenone Accord Healthcare, Eplerenone Krka
Iceland · Eplerenon Bluefish, Eplerenon Krka
Italy · Eplerenone Accord, Eplerenone Doc Generici
Lithuania · Apleria
Luxembourg · Inspra
Latvia · Enplerasa, Plecard
Norway · Eplerenon Accord, Eplerenon Krka
Poland · Eleveon, Enplerasa
Portugal · Eplerenona Biofarmoz, Eplerenona Blovasc
Romania · Apleria, Eplerenonă Arena
Sweden · Eplerenon Accord, Eplerenon Bluefish
Slovenia · Elreptic, Enplerasa
Slovakia · Aldepla, Apleria

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e3193cb1-1f00-45c9-a71f-51397e82a9d3
GET /v1/drugs/e3193cb1-1f00-45c9-a71f-51397e82a9d3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h116346_smpc.pdf",
  "strength": null,
  "atc_label": "Eplerenone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg116346",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "POLYSORBAAT 80 (E 433)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "EPLERENON"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h116346.pdf",
  "authorised_at": "2015/03/06",
  "procedure_number": "NL/H/3666/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "116346",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about eplerenone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console